S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

TG Therapeutics News Headlines (NASDAQ:TGTX)

$5.56
+0.04 (+0.72 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$5.38
Now: $5.56
$5.64
50-Day Range
$5.07
MA: $5.81
$6.98
52-Week Range
$3.32
Now: $5.56
$9.38
Volume662,569 shs
Average Volume1.62 million shs
Market Capitalization$527.33 million
P/E RatioN/A
Dividend YieldN/A
Beta2.5

Headlines

TG Therapeutics (NASDAQ TGTX) News Headlines

Source:
DateHeadline
TG Therapeutics Inc (NASDAQ:TGTX) Sees Large Drop in Short InterestTG Therapeutics Inc (NASDAQ:TGTX) Sees Large Drop in Short Interest
www.americanbankingnews.com - October 16 at 7:38 PM
TG Therapeutics (TGTX) Presents At Cantor Healthcare Conference - SlideshowTG Therapeutics (TGTX) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 4 at 5:32 PM
TG Therapeutics to Present at the 2019 Cantor Global Healthcare ConferenceTG Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - October 2 at 7:41 AM
TG Therapeutics Inc (NASDAQ:TGTX) Expected to Post Earnings of -$0.43 Per ShareTG Therapeutics Inc (NASDAQ:TGTX) Expected to Post Earnings of -$0.43 Per Share
www.americanbankingnews.com - September 30 at 9:43 PM
TG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib ("U2") in BloodTG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib ("U2") in Blood
www.benzinga.com - September 30 at 4:41 PM
TG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib (“U2”) in BloodTG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib (“U2”) in Blood
finance.yahoo.com - September 30 at 4:41 PM
TG Therapeutics Announces Data Presentations at the XVIII International Workshop on Chronic Lymphocytic Leukemia (iwCLL)TG Therapeutics Announces Data Presentations at the XVIII International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
finance.yahoo.com - September 23 at 3:57 PM
Is TG Therapeutics (NASDAQ:TGTX) Using Debt In A Risky Way?Is TG Therapeutics (NASDAQ:TGTX) Using Debt In A Risky Way?
finance.yahoo.com - September 18 at 4:33 PM
TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European CommitteeTG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee
www.nasdaq.com - September 12 at 11:49 AM
TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
finance.yahoo.com - September 12 at 11:49 AM
The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer StudyThe Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study
finance.yahoo.com - September 12 at 11:49 AM
TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS 
finance.yahoo.com - August 29 at 8:01 AM
TG Therapeutics Mourns the Loss of Board Member, Mark Schoenebaum, MDTG Therapeutics Mourns the Loss of Board Member, Mark Schoenebaum, MD
finance.yahoo.com - August 26 at 5:48 PM
Large Option Trader Sells TG Therapeutics Calls After Big RunLarge Option Trader Sells TG Therapeutics Calls After Big Run
www.benzinga.com - August 12 at 5:45 PM
What Kind Of Shareholder Owns Most TG Therapeutics, Inc. (NASDAQ:TGTX) Stock?What Kind Of Shareholder Owns Most TG Therapeutics, Inc. (NASDAQ:TGTX) Stock?
finance.yahoo.com - August 12 at 10:24 AM
Edited Transcript of TGTX earnings conference call or presentation 9-Aug-19 12:30pm GMTEdited Transcript of TGTX earnings conference call or presentation 9-Aug-19 12:30pm GMT
finance.yahoo.com - August 12 at 10:24 AM
BRIEF-TG Therapeutics Reports Q2 Loss Per Share $0.42BRIEF-TG Therapeutics Reports Q2 Loss Per Share $0.42
www.msn.com - August 10 at 10:30 AM
TG Therapeutics EPS beats by $0.02, revenue in-lineTG Therapeutics EPS beats by $0.02, revenue in-line
seekingalpha.com - August 9 at 5:50 PM
TG Therapeutics net loss improves in Q2TG Therapeutics net loss improves in Q2
seekingalpha.com - August 9 at 5:50 PM
TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial ResultsTG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 9 at 5:50 PM
TG Therapeutics Inc (TGTX) Q2 2019 Earnings Call TranscriptTG Therapeutics Inc (TGTX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 5:50 PM
TG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business UpdateTG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business Update
finance.yahoo.com - August 7 at 5:37 PM
Steven Cohen Charges Into ChiasmaSteven Cohen Charges Into Chiasma
finance.yahoo.com - July 31 at 5:23 PM
Here’s What Hedge Fund Think About TG Therapeutics Inc (TGTX)Here’s What Hedge Fund Think About TG Therapeutics Inc (TGTX)
finance.yahoo.com - July 6 at 9:24 AM
TG Therapeutics Announces Presentation of Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis During an Oral Session at the 5th Congress of the European Academy of NeurologyTG Therapeutics Announces Presentation of Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis During an Oral Session at the 5th Congress of the European Academy of Neurology
finance.yahoo.com - July 2 at 9:45 AM
Friday 6/28 Insider Buying Report: BSTZ, TGTXFriday 6/28 Insider Buying Report: BSTZ, TGTX
www.nasdaq.com - June 29 at 9:15 AM
Is TG Therapeutics, Inc.s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - June 27 at 5:34 PM
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - June 27 at 5:34 PM
TG Therapeutics to Present at the Raymond James Life Sciences and MedTech ConferenceTG Therapeutics to Present at the Raymond James Life Sciences and MedTech Conference
finance.yahoo.com - June 18 at 6:38 PM
TG Therapeutics Presents Preclinical Data for TG-1801, a First-in-Class Anti-CD47/CD19 Bispecific Antibody, at the 24th European Hematology Association Annual CongressTG Therapeutics Presents Preclinical Data for TG-1801, a First-in-Class Anti-CD47/CD19 Bispecific Antibody, at the 24th European Hematology Association Annual Congress
finance.yahoo.com - June 17 at 11:20 AM
TG on go with U.S. application for umbralisib in MZLTG on go with U.S. application for umbralisib in MZL
seekingalpha.com - June 11 at 5:43 PM
TG Therapeutics Confirms Registration Path for Umbralisib in Marginal Zone Lymphoma Following FDA MeetingTG Therapeutics Confirms Registration Path for Umbralisib in Marginal Zone Lymphoma Following FDA Meeting
finance.yahoo.com - June 11 at 10:35 AM
TG up 4% on positive umbralisib data in MZLTG up 4% on positive umbralisib data in MZL
seekingalpha.com - June 5 at 5:20 PM
TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual MeetingTG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - June 4 at 5:01 PM
Forensic Value Selections For June: Long-Term Positive Picks Beating Negative By +18.78%Forensic Value Selections For June: Long-Term Positive Picks Beating Negative By +18.78%
seekingalpha.com - June 4 at 10:49 AM
TG Therapeutics to Present at the Jefferies 2019 Healthcare ConferenceTG Therapeutics to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - June 4 at 10:48 AM
TG Therapeutics May Have Potential but the Charts Need More WorkTG Therapeutics May Have Potential but the Charts Need More Work
finance.yahoo.com - May 28 at 10:32 AM
TG Therapeutics CEO: Going through the process to reach big marketsTG Therapeutics CEO: Going through the process to reach big markets
finance.yahoo.com - May 24 at 10:22 AM
TG Therapeutics Announces Data Presentations at Upcoming Medical MeetingsTG Therapeutics Announces Data Presentations at Upcoming Medical Meetings
finance.yahoo.com - May 16 at 8:07 AM
TG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash PositionTG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash Position
seekingalpha.com - May 14 at 10:49 AM
Edited Transcript of TGTX earnings conference call or presentation 10-May-19 12:00pm GMTEdited Transcript of TGTX earnings conference call or presentation 10-May-19 12:00pm GMT
finance.yahoo.com - May 11 at 10:51 AM
TG Therapeutics Inc (TGTX) Q1 2019 Earnings Call TranscriptTG Therapeutics Inc (TGTX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 4:55 PM
Biotech News Recap: Merck Announces Yet Another Successful Readout For A Key AssetBiotech News Recap: Merck Announces Yet Another Successful Readout For A Key Asset
seekingalpha.com - May 10 at 10:43 AM
TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial ResultsTG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 10 at 10:43 AM
TG Therapeutics net loss improves in Q1TG Therapeutics net loss improves in Q1
seekingalpha.com - May 10 at 10:43 AM
TG Therapeutics to Host Conference Call on First Quarter 2019 Financial Results and Business UpdateTG Therapeutics to Host Conference Call on First Quarter 2019 Financial Results and Business Update
finance.yahoo.com - May 9 at 10:41 AM
Ublituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeksUblituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeks
www.globenewswire.com - May 7 at 10:27 AM
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual MeetingTG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting
finance.yahoo.com - May 7 at 10:27 AM
Did TG Therapeutics, Inc. (NASDAQ:TGTX) Insiders Sell Shares?Did TG Therapeutics, Inc. (NASDAQ:TGTX) Insiders Sell Shares?
finance.yahoo.com - April 16 at 4:49 PM
TG Therapeutics receives ODD for umbralisibTG Therapeutics receives ODD for umbralisib
seekingalpha.com - April 15 at 5:17 PM
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Featured Article: What is a Roth IRA?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel